Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Michael Dodd

NOVO NORDISK POSTDOCTORAL RESEARCH FELLOW (2014-2017)

  • Project: Hypoxic signalling in the type 2 diabetic heart – mechanisms for therapeutic modulation

Biography

Michael was awarded a Novo Nordisk Postdoctoral Research Fellowship in 2014, working in Dr Lisa Heather's group in the Department of Physiology, Anatomy & Genetics.  The focus of his fellowship involved understanding how cardiac metabolism is altered during both diabetes and hypoxia, using cardiac cells. In particular, he wanted to know if diabetes affects the induction of the hypoxia signalling pathway, and if so, what component of diabetes inhibits this pathway. Michael also worked on a project with his mentor Dr Bidda Rolin from Novo Nordisk, to understand transcriptional changes in the diabetic heart following short-term global hypoxia.

Following his Novo Nordisk fellowship, in April 2018, Michael was appointed as a Lecturer in Biosciences in the Faculty of Health and Life Sciences at Coventry University, UK. Michael expanded on his teaching experience from Oxford and is continuing to research the relationship between fatty acids and diabetic complications. This has developed further into researching both the role that fatty acids play in breast cancer and their ability to increase hypoxic damage in peripheral tissue. In Aug 2020 Michael was appointed to Assistant Professor (Research) in the Centre for Sport, Exercise and Life Sciences at Coventry University and currently sits on the Biochemical Society’s Education, Training & Public Engagement Committee and Early Career Advisory Panel.